Transpharma International
The computed 12-month bankruptcy probability of Transpharma International is 2.0% (moderate). The 2024 annual accounts show equity of €712k and a net result of €147k. Equity is growing by ~50.6% per year across the filed fiscal years. Its solvency ranks better than 70% of 120 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €712k |
| Net result | €147k |
| Staff (FTE) | 29.4 |
| Better than sector | 70% |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 39.1% | 20.8% | |
| Net result | €147k | €19k | |
| Equity | €712k | €144k | |
| Gross operating margin | €2.18M | €179k | |
| Staff costs | €1.83M | €242k |
Show 11 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €328k |
| Net profit | €147k |
| Cash flow | €230k |
| Staff costs | €1.83M |
| Income taxes | €63k |
| Dividends | - |
| Total assets | €1.82M |
| Equity | €712k |
| Debt | €1.11M |
| of which ≤ 1y | €853k |
| of which > 1y | €109k |
| Working capital | €428k |
| Employees (FTE) | 29.4 |
| 2024 | |
|---|---|
| Current ratio | 1.50 |
| Quick ratio | 1.50 |
| Working capital ratio | 23.6% |
| Solvency | 39.1% |
| Debt / equity | 1.56 |
| Long-term debt ratio | 0.15 |
| Interest coverage | 8.95 |
| Gross margin | - |
| Net margin | - |
| ROA | 8.1% |
| ROE | 20.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (24 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.82M |
| Fixed assets | 21/28 | €537k |
| Intangible fixed assets | 21 | €362k |
| Tangible fixed assets | 22/27 | €24k |
| Financial fixed assets | 28 | €151k |
| Current assets | 29/58 | €1.28M |
| Amounts receivable within one year | 40/41 | €1.11M |
| Cash & bank | 54/58 | €164k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.82M |
| Equity | 10/15 | €712k |
| Contributions / capital | 10/11 | €1k |
| Accumulated profits (losses) | 14 | €711k |
| Amounts payable | 17/49 | €1.11M |
| Amounts payable after one year | 17 | €109k |
| Amounts payable within one year | 42/48 | €853k |
| Trade debts payable within one year | 44 | €354k |
| Income statement | ||
| Gross operating margin | 9900 | €2.18M |
| Operating result | 9901 | €245k |
| Financial income | 75 | €2k |
| Financial charges | 65 | €37k |
| Result before taxes | 9903 | €210k |
| Income taxes | 67/77 | €63k |
| Net result for the period | 9904 | €147k |
| Result to be appropriated | 9905 | €147k |
-
TRANSPHARMA INTERNATIONAL HOLDING B.V.Legal entityDirector· perm. rep.: Laure BrenasState Gazette act 25044293 (03-04-2025)Current18-03-2025 → present
-
Current08-11-2024 → present
-
Current07-11-2024 → present
-
Current07-11-2024 → present
-
Current29-05-2024 → present
Former directors (1)
-
Former29-05-2024 → 08-11-2024
2 events
- 08-11-2024 Resigned· Managing director
- 29-05-2024 Appointed· Managing director
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Forvis Mazars Advisory ServicesCurrent Statutory auditor · represented by Koen Potters |
- | 07-07-2022 → present |
| Forvis Mazars Réviseurs d’EntreprisesCurrent Statutory auditor · represented by Koen Potters |
- | 14-10-2022 → present |
| NACE primary | Logistieke diensten(52250) |
| Legal form | Private limited company(610) |
| Incorporation | 22-03-2021 |
| Status | Active |
| Postal code | 9320 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 41342B1729/00A000 | Flanders | 4.6 ha | 1 · 1.4 ha | 17.7 m |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 13 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
31-07-2025 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.495.888",
"name_full": "TRANSPHARMA INTERNATIONAL",
"legal_form": "BV"
}
}03-04-2025 Laure Brenas appointed as director
- Laure Brenas, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Laure Brenas",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "TRANSPHARMA INTERNATIONAL HOLDING B.V.",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-03-18",
"evidence_quote": "De enige aandeelhouder beslist tot de benoeming als bestuurder van de Vennootschap met onmiddellijke ingang en voor onbepaalde duur: TRANSPHARMA INTERNATIONAL HOLDING B.V. (een vennootschap naar het recht van Nederland, met zetel te Keltenweg 70, 5342LP Oss, Nederland, en met KvK-nummer 81023782), m"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.495.888",
"name_full": "TRANSPHARMA INTERNATIONAL",
"legal_form": "BV"
}
}05-03-2025 Koen Potters reappointed as statutory auditor
- Koen Potters, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Koen Potters",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0428837889",
"name": "Forvis Mazars Bedrijfsrevisoren BV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De enige aandeelhouder beslist om Forvis Mazars Bedrijfsrevisoren BV (met zetel te Bolwerklaan 21 bus 8, 1210 Sint-Joost-ten-Node, gekend onder het KBO-nummer 0428.837.889), vertegenwoordigd door de heer Koen Potters, te herbenoemen als commissaris van de Vennootschap."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.495.888",
"name_full": "TRANSPHARMA INTERNATIONAL",
"legal_form": "BV"
}
}05-12-2024 3 directors appointed, 1 resigning
- Stéphane Baudry, Bestuurder
- Benoit Latteur, Bestuurder
- Peter Roelands, Gedelegeerd bestuurder
- Michiel Heller, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "St\u00E9phane Baudry",
"address": null,
"birth_date": null
},
"effective_date": "2024-11-07",
"evidence_quote": "De enige aandeelhouder beslist tot de benoeming als bestuurder van de Vennootschap van volgende personen en zulks met onmiddellijke ingang en voor onbepaalde duur: (i) De heer St\u00E9phane Baudry, hebbende de Franse nationaliteit, die woonplaats kiest op de zetel van de Vennootschap;"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Benoit Latteur",
"address": null,
"birth_date": null
},
"effective_date": "2024-11-07",
"evidence_quote": "De enige aandeelhouder beslist tot de benoeming als bestuurder van de Vennootschap van volgende personen en zulks met onmiddellijke ingang en voor onbepaalde duur: (ii) De heer Benoit Latteur."
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Michiel Heller",
"address": null,
"birth_date": null
},
"effective_date": "2024-11-08",
"evidence_quote": "De bestuurders beslissen een einde te stellen aan het mandaat van de heer Michiel Heller als gedelegeerde tot het dagelijks bestuur, zulks met onmiddellijke ingang."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Peter Roelands",
"address": null,
"birth_date": null
},
"effective_date": "2024-11-08",
"evidence_quote": "De bestuurders beslissen tot de benoeming van de heer Peter Roelands als gedelegeerde tot het dagelijks bestuur van de Vennootschap, met het recht om alleen op te treden, zulks met onmiddellijke ingang en voor onbepaalde duur."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.495.888",
"name_full": "TRANSPHARMA INTERNATIONAL",
"legal_form": "BV"
}
}25-11-2024 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.495.888",
"name_full": "TRANSPHARMA INTERNATIONAL",
"legal_form": "BV"
}
}25-07-2024 2 directors appointed
- Nick Sims, Gedelegeerd bestuurder
- Michiel Heller, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Nick Sims",
"address": null,
"birth_date": null
},
"effective_date": "2024-05-29",
"evidence_quote": "De enige bestuurder beslist tot de benoeming als gedelegeerden tot het dagelijks bestuur van de Vennootschap elk met het recht om alleen op te treden, zulks met onmiddellijke ingang en voor onbepaalde duur: - de heer Nick Sims; en - de heer Michiel Heller."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Michiel Heller",
"address": null,
"birth_date": null
},
"effective_date": "2024-05-29",
"evidence_quote": "De enige bestuurder beslist tot de benoeming als gedelegeerden tot het dagelijks bestuur van de Vennootschap elk met het recht om alleen op te treden, zulks met onmiddellijke ingang en voor onbepaalde duur: - de heer Nick Sims; en - de heer Michiel Heller."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.495.888",
"name_full": "TRANSPHARMA INTERNATIONAL",
"legal_form": "BV"
}
}02-04-2024 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.495.888",
"name_full": "TRANSPHARMA INTERNATIONAL",
"legal_form": "BV"
}
}15-09-2023 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.495.888",
"name_full": "TRANSPHARMA INTERNATIONAL",
"legal_form": "BV"
}
}14-10-2022 Koen POTTERS appointed as statutory auditor
- Koen POTTERS, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Koen POTTERS",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0428837889",
"name": "MAZARS BEDRIJFSREVISOREN",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De enige aandeelhouder beslist unaniem om de besloten vennootschap MAZARS BEDRIJFSREVISOREN (B00021), met ondernemingsnummer BE 0428.837.889, vertegenwoordigd door de heer Koen POTTERS, met maatschappelijke zetel te 2600 Berchem (Antwerpen), Berchemstadionstraat, 78, te benoemen als commissaris van "
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.495.888",
"name_full": "TRANSPHARMA INTERNATIONAL",
"legal_form": "BV"
}
}07-07-2022 Koen Potters appointed as statutory auditor
- Koen Potters, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Koen Potters",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0844915134",
"name": "MAZARS ADVISORY SERVICES",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De enige aandeelhouder beslist unaniem om de besloten vennootschap MAZARS ADVISORY SERVICES, met ondernemingsnummer 0844.915.134, vertegenwoordigd door de heer Koen Potters, met maatschappelijke zetel te Bolwerklaan 21 bus 8, Sint-Joost-ten-Node, en vestigingsadres Berchemstadionstraat 78, 2600 Antw"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.495.888",
"name_full": "TRANSPHARMA INTERNATIONAL",
"legal_form": "BV"
}
}01-06-2021 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.495.888",
"name_full": "TRANSPHARMA INTERNATIONAL",
"legal_form": "BV"
}
}24-03-2021 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "Waterkeringstraat 1, 9320 Aalst",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0759.592.944",
"name": "De besloten vennootschap naar Nederland recht \u201CTransPharma International Holding B.V.\u201D"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Aandelen",
"partner_role": null,
"holder_org_kbo": "0759.592.944",
"holder_org_name": "De besloten vennootschap naar Nederland recht \u201CTransPharma International Holding B.V.\u201D",
"contribution_type": "cash",
"amount_paid_in_eur": 1000,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 1000,
"amount_subscribed_eur": 1000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 1000,
"subject_company": {
"kbo": "0765.495.888",
"name_full": "Transpharma International",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2021-03-19",
"post_incorporation_mandates": []
}| Legal nameNL | Transpharma International |